Literature DB >> 8642229

How to evaluate interaction between causes: a review of practices in cardiovascular epidemiology.

J Hallqvist1, A Ahlbom, F Diderichsen, C Reuterwall.   

Abstract

To increase the knowledge of interaction or synergy between risk factors in an important task in medical research. Still, current literature in cardiovascular epidemiology reflects major misconceptions as how to evaluate interaction. This paper presents Rothman's model of causation from which strict empirical criteria of interaction can be derived. In principle, the method to apply consists of comparing risk differences for one risk factor of interest across strata of the other. Commonly used but incorrect approaches are exemplified and discussed. These include reporting risk of disease among those with combined exposure, comparing relative risks for one exposure after stratification by level of the other, and including an interaction term in the regression model and drawing conclusions from its P-value.

Mesh:

Year:  1996        PMID: 8642229     DOI: 10.1046/j.1365-2796.1996.431782000.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  33 in total

1.  GEIRA: gene-environment and gene-gene interaction research application.

Authors:  Bo Ding; Henrik Källberg; Lars Klareskog; Leonid Padyukov; Lars Alfredsson
Journal:  Eur J Epidemiol       Date:  2011-04-26       Impact factor: 8.082

Review 2.  Life course epidemiology.

Authors:  D Kuh; Y Ben-Shlomo; J Lynch; J Hallqvist; C Power
Journal:  J Epidemiol Community Health       Date:  2003-10       Impact factor: 3.710

3.  The association and interaction analysis of metabolic syndrome and chronic kidney disease on cardiovascular autonomic neuropathy in the general Chinese population.

Authors:  Jin Zhang; Nai-Jia Liu; Yan Zhang; Hong Yang; Zachary Tang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Calculating measures of biological interaction.

Authors:  Tomas Andersson; Lars Alfredsson; Henrik Källberg; Slobodan Zdravkovic; Anders Ahlbom
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

5.  Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS).

Authors:  Takeki Suzuki; Kumiko Hirata; Mitchell S V Elkind; Zhezhen Jin; Tanja Rundek; Yumiko Miyake; Bernadette Boden-Albala; Marco R Di Tullio; Ralph Sacco; Shunichi Homma
Journal:  Am Heart J       Date:  2008-05-27       Impact factor: 4.749

6.  Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study.

Authors:  Takeki Suzuki; Ronit Katz; Nancy Swords Jenny; Neil A Zakai; Martin M LeWinter; Joshua I Barzilay; Mary Cushman
Journal:  Circ Heart Fail       Date:  2008-09-23       Impact factor: 8.790

7.  Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in Chinese.

Authors:  Jie Ge; Lin Zhu; Junde Zhou; Guangxiao Li; Ye Li; Shuying Li; Zhiwei Wu; Jiesheng Rong; Huiping Yuan; Yanhong Liu; Qiang Chi; Daxun Piao; Yashuang Zhao; Binbin Cui
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-22       Impact factor: 4.553

8.  Estimating measures of interaction on an additive scale for preventive exposures.

Authors:  Mirjam J Knol; Tyler J VanderWeele; Rolf H H Groenwold; Olaf H Klungel; Maroeska M Rovers; Diederick E Grobbee
Journal:  Eur J Epidemiol       Date:  2011-02-23       Impact factor: 8.082

9.  Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly.

Authors:  Dena E Rifkin; Ronit Katz; Michel Chonchol; Linda F Fried; Jie Cao; Ian H de Boer; David S Siscovick; Michael G Shlipak; Mark J Sarnak
Journal:  Nephrol Dial Transplant       Date:  2009-12-15       Impact factor: 5.992

10.  Early exposure to secondhand tobacco smoke and the development of allergic diseases in 4 year old children in Malmö, Sweden.

Authors:  Kristina Hansen; Elisabeth Mangrio; Martin Lindström; Maria Rosvall
Journal:  BMC Pediatr       Date:  2010-08-23       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.